146 related articles for article (PubMed ID: 30700206)
1. Understanding Pathways to the Diagnosis of Thyroid Cancer: Are There Ways We Can Reduce Over-Diagnosis?
Rahman ST; McLeod DSA; Pandeya N; Neale RE; Bain CJ; Baade P; Youl PH; Jordan SJ
Thyroid; 2019 Mar; 29(3):341-348. PubMed ID: 30700206
[TBL] [Abstract][Full Text] [Related]
2. The rising trend in papillary thyroid carcinoma. True increase or over diagnosis?
Hajeer MH; Awad HA; Abdullah NI; Almuhaisen GH; Abudalu LE
Saudi Med J; 2018 Feb; 39(2):147-153. PubMed ID: 29436563
[TBL] [Abstract][Full Text] [Related]
3. Influence of tumor extent on central lymph node metastasis in solitary papillary thyroid microcarcinomas: a retrospective study of 1092 patients.
Yin X; Liu C; Guo Y; Li X; Shen N; Zhao X; Yu P; Wang S; Liu Z
World J Surg Oncol; 2017 Jul; 15(1):133. PubMed ID: 28716127
[TBL] [Abstract][Full Text] [Related]
4. Tall cell variant of papillary thyroid carcinoma: a population-based study in Iceland.
Axelsson TA; Hrafnkelsson J; Olafsdottir EJ; Jonasson JG
Thyroid; 2015 Feb; 25(2):216-20. PubMed ID: 25322334
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of thyroid cancer at a medical screening center: pathological features of screen-detected thyroid carcinomas.
Choi YJ; Park YL; Koh JH
Yonsei Med J; 2008 Oct; 49(5):748-56. PubMed ID: 18972595
[TBL] [Abstract][Full Text] [Related]
6. Rethinking Low-Risk Papillary Thyroid Cancers < 1cm (Papillary Microcarcinomas): An Evidence Review for Recalibrating Diagnostic Thresholds and/or Alternative Labels.
Ma T; Semsarian CR; Barratt A; Parker L; Kumarasinghe MP; Bell KJL; Nickel B
Thyroid; 2021 Nov; 31(11):1626-1638. PubMed ID: 34470465
[No Abstract] [Full Text] [Related]
7. Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors.
Nikiforov YE; Seethala RR; Tallini G; Baloch ZW; Basolo F; Thompson LD; Barletta JA; Wenig BM; Al Ghuzlan A; Kakudo K; Giordano TJ; Alves VA; Khanafshar E; Asa SL; El-Naggar AK; Gooding WE; Hodak SP; Lloyd RV; Maytal G; Mete O; Nikiforova MN; Nosé V; Papotti M; Poller DN; Sadow PM; Tischler AS; Tuttle RM; Wall KB; LiVolsi VA; Randolph GW; Ghossein RA
JAMA Oncol; 2016 Aug; 2(8):1023-9. PubMed ID: 27078145
[TBL] [Abstract][Full Text] [Related]
8. Factors Associated With Diagnosis and Treatment of Thyroid Microcarcinomas.
Esfandiari NH; Hughes DT; Reyes-Gastelum D; Ward KC; Hamilton AS; Haymart MR
J Clin Endocrinol Metab; 2019 Dec; 104(12):6060-6068. PubMed ID: 31415089
[TBL] [Abstract][Full Text] [Related]
9. Papillary thyroid cancer incidence in the volcanic area of Sicily.
Pellegriti G; De Vathaire F; Scollo C; Attard M; Giordano C; Arena S; Dardanoni G; Frasca F; Malandrino P; Vermiglio F; Previtera DM; D'Azzò G; Trimarchi F; Vigneri R
J Natl Cancer Inst; 2009 Nov; 101(22):1575-83. PubMed ID: 19893009
[TBL] [Abstract][Full Text] [Related]
10. Frequent, aggressive behaviors of thyroid microcarcinomas in korean patients.
Lee J; Rhee Y; Lee S; Ahn CW; Cha BS; Kim KR; Lee HC; Kim SI; Park CS; Lim SK
Endocr J; 2006 Oct; 53(5):627-32. PubMed ID: 16896263
[TBL] [Abstract][Full Text] [Related]
11. Time trends for thyroid cancer in northwestern Spain: true rise in the incidence of micro and larger forms of papillary thyroid carcinoma.
Rego-Iraeta A; Pérez-Méndez LF; Mantinan B; Garcia-Mayor RV
Thyroid; 2009 Apr; 19(4):333-40. PubMed ID: 19355823
[TBL] [Abstract][Full Text] [Related]
12. [From macro to micro thyroid carcinoma: records of a clinical hospital from 1991 to 2010].
Mosso L; Campusano C; González H; Domínguez JM; Salman P; Suazo V; Solar A; Cerda J
Rev Med Chil; 2013 Apr; 141(4):442-8. PubMed ID: 23900364
[TBL] [Abstract][Full Text] [Related]
13. Natural history of thyroid cancer [Review].
Takano T
Endocr J; 2017 Mar; 64(3):237-244. PubMed ID: 28154351
[TBL] [Abstract][Full Text] [Related]
14. Impact of estrogen and progesterone receptor expression on the clinical and molecular features of papillary thyroid cancer.
Vannucchi G; De Leo S; Perrino M; Rossi S; Tosi D; Cirello V; Colombo C; Bulfamante G; Vicentini L; Fugazzola L
Eur J Endocrinol; 2015 Jul; 173(1):29-36. PubMed ID: 25862786
[TBL] [Abstract][Full Text] [Related]
15. Thyroid Cancer Screening in South Korea Increases Detection of Papillary Cancers with No Impact on Other Subtypes or Thyroid Cancer Mortality.
Ahn HS; Kim HJ; Kim KH; Lee YS; Han SJ; Kim Y; Ko MJ; Brito JP
Thyroid; 2016 Nov; 26(11):1535-1540. PubMed ID: 27627550
[TBL] [Abstract][Full Text] [Related]
16. The Prevalence of Extranodal Extension in Papillary Thyroid Cancer Based on the Size of the Metastatic Node: Adverse Histologic Features Are Not Limited to Larger Lymph Nodes.
Rowe ME; Ozbek U; Machado RA; Yue LE; Hernandez-Prera JC; Valentino A; Qazi M; Brandwein-Weber M; Liu X; Wenig BM; Urken ML
Endocr Pathol; 2018 Mar; 29(1):80-85. PubMed ID: 29396810
[TBL] [Abstract][Full Text] [Related]
17. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
Mazzaferri EL; Jhiang SM
Am J Med; 1994 Nov; 97(5):418-28. PubMed ID: 7977430
[TBL] [Abstract][Full Text] [Related]
18. Do all detected thyroid cancers correspond to 'real cancer'?
Alimoglu O; Dilek HF; Tonyali M; Eren T
Br J Surg; 2020 Jul; 107(8):e276. PubMed ID: 32449153
[No Abstract] [Full Text] [Related]
19. Pre-operative features of non-invasive follicular thyroid neoplasms with papillary-like nuclear features: An analysis of their cytological, Gene Expression Classifier and sonographic findings.
Song SJ; LiVolsi VA; Montone K; Baloch Z
Cytopathology; 2017 Dec; 28(6):488-494. PubMed ID: 29165886
[TBL] [Abstract][Full Text] [Related]
20. Thyroid cancer: is the incidence rise abating?
Sassolas G; Hafdi-Nejjari Z; Remontet L; Bossard N; Belot A; Berger-Dutrieux N; Decaussin-Petrucci M; Bournaud C; Peix JL; Orgiazzi J; Borson-Chazot F
Eur J Endocrinol; 2009 Jan; 160(1):71-9. PubMed ID: 18952764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
